SanBio has been granted a patent for a method and culture medium to induce polarization in multipotent stem cells. The method involves using specific agents and ligands to produce therapeutic cells and extracellular vesicles. GlobalData’s report on SanBio gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on SanBio, NSAID cancer drugs was a key innovation area identified from patents. SanBio's grant share as of May 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.